Back to Search Start Over

Nasopharyngeal Carriage of Streptococcus pneumoniae in Tunisian Healthy under-Five Children during a Three-Year Survey Period (2020 to 2022).

Authors :
Ben Ayed N
Ktari S
Jdidi J
Gargouri O
Smaoui F
Hachicha H
Ksibi B
Mezghani S
Mnif B
Mahjoubi F
Hammami A
Source :
Vaccines [Vaccines (Basel)] 2024 Apr 09; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 09.
Publication Year :
2024

Abstract

We aimed to assess the prevalence of nasopharyngeal pneumococcal carriage and to determine serotype distribution, antibiotic susceptibility patterns, and evolutionary dynamics of Streptococcus pneumoniae isolates in healthy under-five children. Nasopharyngeal swabs were collected from healthy children over three survey periods between 2020 and 2022. All pneumococcal isolates were serotyped and tested for antimicrobial susceptibility. A total of 309 S. pneumoniae isolates were collected, with an overall prevalence of nasopharyngeal pneumococcal carriage of 24.4% (CI95%: [22-26.8%]). These isolates were classified into 25 different serotypes. The most common serotypes were 14 (14.9%), 19F (12%), 6B (10.4%), and 23F (7.4%), which are covered by the PCV10 vaccine, as well as 19A (8.4%) and 6A (7.8%), which are covered by the PCV13 vaccine. A significant decrease in the proportion of serotype 19F ( p = 0.001) and an increase in serotypes 19A ( p = 0.034) and 6A ( p = 0.029) were observed between the three survey periods. Multidrug resistance (MDR) was noted for 56.6% of the isolates. A significant association with antimicrobial resistance was observed for the most frequent serotypes, mainly serotype 19A. In conclusion, one-quarter of healthy under-five children in Tunisia carried S. pneumoniae in their nasopharynx. A dominance of vaccine serotypes significantly associated with antimicrobial resistance was recorded.

Details

Language :
English
ISSN :
2076-393X
Volume :
12
Issue :
4
Database :
MEDLINE
Journal :
Vaccines
Publication Type :
Academic Journal
Accession number :
38675775
Full Text :
https://doi.org/10.3390/vaccines12040393